a precision oncology biotech company pioneering clinical grade single-cell tumour profiling
One Biosciences has raised €15M across 1 funding round from 8 investors, most recently a Series A round in Jul 2025. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-17 | Series A | €15M |
| Adamed Technology,Blast,Galion.exe,Invus,Kima Ventures,Polytechnique Ventures+2 more |
| View deal → |
